4.7 Review

Extracellular vesicles in cancer diagnostics and therapeutics

Journal

PHARMACOLOGY & THERAPEUTICS
Volume 223, Issue -, Pages -

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pharmthera.2021.107806

Keywords

Extracellular vesicles; Tumor microenvironment; Cancer metastasis; Diagnosis; Therapeutics

Funding

  1. National Research Foundation of Korea (NRF) grant from the Korean government (MSIT) [NRF2019R1A2C1003003]

Ask authors/readers for more resources

Cell-to-cell interactions within the tumor microenvironment play a crucial role in cancer promotion, development, and malignant transformation. Extracellular vesicles (EVs), including exosomes and microvesicles, mediate the transportation of regulatory molecules between cells and to distant sites, contributing to the formation of premetastatic niches and the progression of malignancies. EVs have potential applications in disease diagnosis, prognosis, and therapeutics in the field of cancer research.
Cancer promotion, development, and malignant transformation is greatly influenced by cell-to-cell interactions in a complex tissue microenvironment. Cancer and stromal cells secrete soluble factors, as well as deport membrane-encapsulated structures, which actively contribute and mediate cell-to-cell interaction within a tumor microenvironment (TME). These membrane structures are recognized as extracellular vesicles (EVs), which include exosomes and microvesicles. They can carry and transport regulatory molecules such as oncogenic proteins, coding and non-coding RNAs, DNA, and lipids between neighboring cells and to distant sites. EVs medi-ate crucial pathophysiological effects such as the formation of premetastatic niches and the progression of malig-nancies. There is compelling evidence that cancer cells exhibit a significant amount of EVs, which can be released into the surrounding body fluids, compared with nonmalignant cells. EVs therefore have the potential to be used as disease indicator for the diagnosis and prognosis of cancers, as well as for facilitating research into the under-lying mechanism and biomolecular basis of these diseases. Because of their ability to transport substances, followed by their distinct immunogenicity and biocompatibility, EVs have been used to carry therapeutically-active molecules such as RNAs, proteins, short and long peptides, and various forms of drugs. In this paper, we summarize new advancement in the biogenesis and physiological roles of EVs, and underpin their functional im-pacts in the process of cancer growth and metastasis. We further highlight the therapeutic roles of EVs in the treatment, prevention, and diagnosis of human malignancies. (c) 2021 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available